Paysign Inc. (PAYS)
NASDAQ (CM) NASDAQ (CM) Primary 
CXA Summary
Does Paysign (PAYS) Have the Potential to Rally 74% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 74% in Paysign (PAYS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
What Makes Paysign (PAYS) a New Buy Stock
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Paysign, Inc. (PAYS) Q3 2025 Earnings Call Transcript
Paysign, Inc. ( PAYS ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Mark Newcomer - Co-Founder, President & CEO Jeffery Baker - CFO & Treasurer Matthew Turner - President of Patient Affordability Conference Call Participants Jacob Stephan - Lake Street Capital Markets, LLC, Research Division Gary Prestopino - Barrington Research Associates, Inc., Research Division Peter Heckmann - D.A. Davidson & Co., Research Division Presentation Operator Good afternoon.
Paysign Inc. (PAYS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Paysign Inc. ever had a stock split?
Paysign Inc. Profile
| Transportation Infrastructure Industry | Industrials Sector | Mark R. Newcomer CEO | NASDAQ (CM) Exchange | 70451A104 CUSIP |
| US Country | 173 Employees | - Last Dividend | 30 Dec 2005 Last Split | 2 Apr 1998 IPO Date |
Overview
Paysign, Inc. specializes in offering a broad spectrum of prepaid card programs, patient affordability options, digital banking services, and integrated payment processing for a diverse clientele including businesses, consumers, and government institutions. Initially known as 3PEA International, Inc., the company underwent a name change to Paysign, Inc. in April 2019, showcasing its evolution and broadening its focus. Founded in 1995 and operating from its headquarters in Henderson, Nevada, Paysign extends its market presence primarily towards organizations and municipalities in need of efficient payment solutions for various purposes such as rewards, rebates, and payment assistance. This rebranding and strategic positioning reflect Paysign's commitment to innovation in payment solutions.
Products and Services
- Prepaid Card Programs: Offers an array of prepaid solutions including corporate rewards, prepaid gift cards, and general-purpose reloadable debit cards. These are tailored for corporations seeking streamlined methods for distributing rewards, consumer rebates, and more efficient payroll disbursement.
- Patient Affordability Offerings: Specializes in healthcare-related payment solutions like pharmacy payment assistance and healthcare reimbursement payments. These services aim to facilitate smoother transactions within the healthcare industry, ensuring that patients can afford their medications and treatments through innovative payment solutions.
- Digital Banking Services: Provides digital banking solutions, including demand deposit accounts that come with a debit card, enabling easier access to funds. This service is designed for both individuals and businesses in need of straightforward, reliable banking and payment options.
- Integrated Payment Processing: Offers comprehensive payment processing services that cater to a wide range of transaction needs for businesses, governments, and individual consumers. This includes processing for various types of payments and transfers, ensuring secure and efficient financial operations.
- Employee Incentives and Consumer Rebates: Delivers customized solutions for organizations to provide incentives to employees or rebates to consumers effectively. These programs are crafted to enhance motivation and satisfaction, contributing to better engagement and consumer loyalty.
- Donor Compensation and Clinical Trials: Provides specialized payment solutions for compensating donors and managing financial transactions related to clinical trials. These services are particularly geared towards organizations in the biomedical and pharmaceutical sectors, requiring precise and ethical handling of payments.
Contact Information
